<p>This is a $63,112.50 firm fixed price purchase order contract awarded by the Office of Naval Research (ONR), a defense agency, to Quantum Si Incorporated, a self-certified small disadvantaged business. The contract is for the provision of sequencing reagents and chips to support 4 sequencing runs on a Platinum(R) system. The contract has an ultimate completion date of June 18, 2025 and was awarded on February 20, 2025. No set-aside was used for this contract.</p>
This federal contract award, valued at $72,865.00, was issued by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Covaris, LLC, a for-profit manufacturer of genomic research tools and technologies. The contract is for the delivery of a Covaris ML230 focused ultrasonicator instrument and associated installation services to support the Genomics & Bioinformatics Department of BUMED's Biological Defense Research Directorate (BDRD). The original...
This federal contract award from the Bureau of Naval Personnel, a defense agency, was granted to Quantum Design, Inc., a for-profit manufacturing company, for the delivery of a specialized magnetometer instrument. The $229,680.00 firm fixed-price purchase order contract has an ultimate completion date of April 15, 2016. The contract was designated as a total small business set-aside. Quantum Design has previously served as both a prime contractor and subcontractor for various government...
This federal contract award, valued at $141,313.00, was issued by the Department of the Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for the provision of a NovaSeq 6000 Silver Support Plan, which includes maintenance and support services for this critical laboratory equipment used by the Naval Medical Research Command (NMRC) for mission-critical sequencing capabilities. The contract...
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for $97,678.20. The award provides Illumina's RNA sequencing products and reagents to support the Naval Health Research Center's (NHRC) laboratory work characterizing biological threats. The contract has a period of performance through December 1, 2021. This award is not associated with a set-aside program. Illumina has previously...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed-price purchase order to Quanterix Corporation, a for-profit life sciences company, for a QUANTERIX SP - X IMAGING ANALYSIS SYSTEM valued at $147,321.00. This award, which does not have a set-aside designation, supports the agency's efforts related to the COVID-19 national interest action. Quanterix has received over $30 million in prior federal contracts from agencies including the NIH, VA, and DoD to supply its Simoa...
<p>This is a firm fixed-price purchase order contract awarded by the Office of Naval Research (ONR), a defense agency, to Quantum Si Incorporated, a small disadvantaged business manufacturer. The contract has a ceiling value of $170,500.00 and a completion date of September 12, 2025. The contract is to provide OUSD-funded bioprototyping services. No set-aside designation was used for this award.</p>
This federal contract award, with a value of $92,170.00, was made by the Bureau of Medicine and Surgery (BUMED) of the U.S. Navy to Cepheid, a subsidiary of Danaher Corporation. The contract is for the delivery of a GeneXpert IV-4 site system, a black and white printer, and related services and maintenance for one year. This sole-source contract was awarded under the XPRSARS-COV2-10 requirement, which supports the Navy's laboratories at the Naval Health Research Center (NHRC) in San Diego. The...
This federal contract award is for the purchase of a "QIACUBE FULL AGREEMENT" by the Bureau of Medicine and Surgery (BUMED), a Defense agency, for $10,262.00 over a 12-month period. The contract was awarded to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. Qiagen provides sample and assay technologies for molecular diagnostics, applied testing, and other applications to support federal agencies' biomedical research, public health, and healthcare...
This is a firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for MiSeq maintenance and service. The contract has a ceiling value of $125,421.00 and a period of performance from August 29, 2022, to August 29, 2025. The contract does not have a set-aside designation. Illumina is a manufacturer and provider of genetic and genomic analysis instruments and reagents, and has previously...